Across the past 12 months, open-market trades by PMV Pharmaceuticals insiders were all sales, totaling $1.52 million (1Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Advisors Llc Orbimed | TenPercentOwner | 0 | 4,975,291 | 4,975,291 | 86.8% | 27 Oct, 2025 |
| 2 | David Henry Mack | President And Ceo | 451,109 | 0 | 451,109 | 7.9% | 29 Oct, 2025 |
| 3 | Robert Ticktin | General Counsel Coo | 98,695 | 0 | 98,695 | 1.7% | 03 Jul, 2025 |
| 4 | Deepika Jalota | Chief Development Officer | 89,959 | 0 | 89,959 | 1.6% | 03 Jul, 2025 |
| 5 | Michael Carulli | Chief Financial Officer | 60,146 | 0 | 60,146 | 1.0% | 03 Jul, 2025 |
| 6 | Leila Alland | Chief Medical Officer | 45,909 | 0 | 45,909 | 0.8% | 18 Sep, 2023 |
| 7 | Winston Kung | Coo, Cfo | 10,600 | 0 | 10,600 | 0.2% | 30 Jan, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Oct, 2026 | Matthew Joseph Eckler | Director | Acquired A | 84,000 | $0.00 | $0 | 84,000 | Direct |
| 04 Jun, 2026 | Carol Giltner Gallagher | Director | Acquired A | 42,000 | $0.00 | $0 | 42,000 | Direct |
| 04 Jun, 2026 | Laurie Stelzer | Director | Acquired A | 42,000 | $0.00 | $0 | 42,000 | Direct |
| 04 Jun, 2026 | Charles M Baum | Director | Acquired A | 42,000 | $0.00 | $0 | 42,000 | Direct |
| 04 Jun, 2026 | Arnold J Levine | Director | Acquired A | 42,000 | $0.00 | $0 | 42,000 | Direct |
| 04 Jun, 2026 | Kirsten Flowers | Director | Acquired A | 42,000 | $0.00 | $0 | 42,000 | Direct |
| 04 Jun, 2026 | Carol Giltner Gallagher | Director | Disposed G | 42,000 | $0.00 | $0 | 0 | Direct |
| 04 Jun, 2026 | Carol Giltner Gallagher | Director | Acquired G | 42,000 | $0.00 | $0 | 42,000 | Indirect |
| 05 Mar, 2026 | David Henry Mack | President And Ceo | Acquired A | 744,960 | $0.00 | $0 | 744,960 | Direct |
| 05 Mar, 2026 | Deepika Jalota | Chief Development Officer | Acquired A | 303,310 | $0.00 | $0 | 303,310 | Direct |
| 05 Mar, 2026 | Robert Ticktin | General Counsel Coo | Acquired A | 319,270 | $0.00 | $0 | 319,270 | Direct |
| 05 Mar, 2026 | Michael Carulli | Chief Financial Officer | Acquired A | 240,000 | $0.00 | $0 | 240,000 | Direct |
| 27 Oct, 2025 | David Henry Mack | President And Ceo | Acquired M | 220,643 | $1.37 | $302.28K | 451,109 | Direct |
| 27 Oct, 2025 | David Henry Mack | President And Ceo | Disposed M | 220,643 | $0.00 | $0 | 0 | Direct |
| 23 Oct, 2025 | Advisors Llc Orbimed | TenPercentOwner | Disposed S | 1,000,000 | $1.52 | $1.52Mn | 4,975,291 | Indirect |
| 10 Sep, 2025 | Advisors Llc Orbimed | TenPercentOwner | Disposed S | 500,000 | $1.80 | $900.00K | 5,975,291 | Indirect |
| 01 Jul, 2025 | Michael Carulli | Chief Financial Officer | Disposed S | 28,249 | $1.06 | $30.08K | 60,146 | Direct |
| 01 Jul, 2025 | Deepika Jalota | Chief Development Officer | Disposed S | 33,065 | $1.06 | $35.20K | 89,959 | Direct |
| 01 Jul, 2025 | Robert Ticktin | General Counsel Coo | Disposed S | 23,151 | $1.06 | $24.65K | 98,695 | Direct |
| 01 Jul, 2025 | David Henry Mack | President And Ceo | Disposed S | 58,411 | $1.06 | $62.18K | 536,133 | Direct |